Fig. 6From: Therapeutic effects of Lucilia sericata larval excretion/secretion products on Leishmania major under in vitro and in vivo conditionsReduction in infection rate and viability of amastigotes upon treatment with the crude ES, fractionated ES and GlucantimeBack to article page